J.M. Forbes & Co’s Ginkgo Bioworks DNA Stock Holding History

J.M. Forbes & Co’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.91M	Sell	999,911 -28,480	-3%	-$238K	0.78%	42
2026 Q1	$6.3M	Sell	1,028,391 -12,050	-1%	-$100K	0.53%	54
2025 Q4	$8.65M	Sell	1,040,441 -19,900	-2%	-$214K	0.7%	42
2025 Q3	$15.5M	Sell	1,060,341 -16,900	-2%	-$202K	1.28%	23
2025 Q2	$12.1M	Sell	1,077,241 -17,323	-2%	-$134K	1.11%	31
2025 Q1	$6.24M	Buy	1,094,564 +392,832	+56%	+$4M	0.6%	52
2024 Q4	$6.89M	Buy	701,732 +576,732	+461%	+$4.94M	0.66%	47
2024 Q3	$1.02M	Buy	+125,000	New	+$1.25M	0.1%	79

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

J.M. Forbes & Co's DNA Position: Q2 2026 in Review

J.M. Forbes & Co reduced its Ginkgo Bioworks (DNA) stake by 2.8% in Q2 2026, selling an estimated $238K and leaving 999,911 shares worth $9.91M. The position accounts for 0.78% of the portfolio, ranked #42.

J.M. Forbes & Co first reported a position in DNA in Q3 2024 and has held it in 8 quarters since. The position peaked at $15.5M in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

J.M. Forbes & Co held 999,911 shares of Ginkgo Bioworks worth $9.91M as of Q2 2026.
J.M. Forbes & Co sold 28,480 Ginkgo Bioworks shares in Q2 2026, an estimated $238K.
Ginkgo Bioworks made up 0.78% of J.M. Forbes & Co's portfolio in Q2 2026, its #42 holding.
J.M. Forbes & Co first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 8 quarters since.
J.M. Forbes & Co's Ginkgo Bioworks position peaked at $15.5M in Q3 2025.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on J.M. Forbes & Co's 13F filing for Q2 2026, filed 20 Jul 2026.